Response to the article by Narla et al “Management of inadequate response and adverse effects to dupilumab in atopic dermatitis”

Risultato della ricerca: Contributo in rivista › Articolo in rivista

Lingua originale	English
pagine (da-a)	e65-e66
Rivista	Journal of the American Academy of Dermatology
Volume	88
DOI	https://doi.org/10.1016/j.jaad.2022.09.055
Stato di pubblicazione	Pubblicato - 2023

Keywords

@article{f8febafe7b4c4b32b7c9962a496dcde9,

title = "Response to the article by Narla et al “Management of inadequate response and adverse effects to dupilumab in atopic dermatitis”",

keywords = "atopic dermatitis, combination therapy, dupilumab, atopic dermatitis, combination therapy, dupilumab",

author = "Niccolo' Gori and Andrea Chiricozzi and Ketty Peris",

year = "2023",

doi = "10.1016/j.jaad.2022.09.055",

language = "English",

volume = "88",

pages = "e65--e66",

journal = "Journal of the American Academy of Dermatology",

issn = "0190-9622",

publisher = "Elsevier Inc.",

}

TY - JOUR

T1 - Response to the article by Narla et al “Management of inadequate response and adverse effects to dupilumab in atopic dermatitis”

AU - Gori, Niccolo'

AU - Chiricozzi, Andrea

AU - Peris, Ketty

PY - 2023

Y1 - 2023

KW - atopic dermatitis

KW - combination therapy

KW - dupilumab

KW - atopic dermatitis

KW - combination therapy

KW - dupilumab

UR - http://hdl.handle.net/10807/229016

U2 - 10.1016/j.jaad.2022.09.055

DO - 10.1016/j.jaad.2022.09.055

M3 - Article

SN - 0190-9622

VL - 88

SP - e65-e66

JO - Journal of the American Academy of Dermatology

JF - Journal of the American Academy of Dermatology

ER -